admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Clearmind Medicine Files Patent Application with USPTO for the Treatment of...

Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional...

Navigating Psychedelics For Clinicians and Wellness Practitioners

Psychedelic Bulletin #142: Terran’s IP Portfolio; AMA Advocates Against Non-Medical Psychedelics;...

COMPASS Pathways plc to announce second quarter 2023 financial results on...

Analysis: Patent Applications Provide Hints at Terran Biosciences’ Strategy

PT427 – The Philosophy of Law Enforcement, The Criminalization of Self-Directed...

Revive Therapeutics Announces Filing of Patent for Bucillamine in the Treatment...

MIND CURE ANNOUNCES LNG ENERGY GROUP CREDIT AGREEMENT IN THE AMOUNT...

1...535455...218 Page 54 of 218

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin